AIDS Weekly and Law

Par Pharmaceutical Companies, Inc. - U.S. FDA approves Megace ES for weight loss in AIDS patients

Pfizer Inc - Pharma company provides development pipeline update

Theratechnologies Inc. - Phase 3 trial of ThGRF for treating HIV-associated lipodystrophy launched

Trinity Biotech plc - Maker of HIV rapid tests announces donation valued at $1,000,000

Tsing Hua University - Researchers' data advance influenza vaccines research

U.S. National Institutes of Health - Protein production by vaccinia virus in cell perfusion bioreactor described

U.S. National Institutes of Health - Research add new data to HIV/AIDS pathogenesis body of knowledge

U.S. National Institutes of Health - Research in HIV/AIDS vaccines provides new insights

U.S. National Institutes of Health - Ritonavir affects basal and catecholamine-stimulated lipolysis in adipocytes

U.S. Natl. Institutes of Health - NIAID funds Center for HIV/AIDS Vaccine Immunology

University of Arizona, Tucson - Reduced micronutrient intake accentuates premature death in murine AIDS

University of Barcelona - Recent findings in HIV/AIDS vaccines provide new insights

University of Bologna - HIV-1 Tat concomitantly downregulates caspase-10/upregulates c-FLIP in T cells

University of Calgary - HIV-related neurological syndromes reduce health-related quality-of-life

University of California, San Diego - CX(3)CR1 polymorphisms predict HIV-1 disease progression in children

University of California, San Francisco - KSHV lytic replication cycle promotes downregulation of cell-surface CD1d

University of Fed Rio de Janeiro - FHIV-1 L89M mutation is high genetic barrier to accumulation of L90M mutations

University of Frankfurt Klinikum - Abacavir + efavirenz effective PI alternative in heavily pretreated HIV patients

University of Heidelberg - HIV Nef establishes superinfection immunity by downregulating CCR5 and CD4

University of Massachusetts - HIV gp120 immunogenicity enhanced when combined with recombinant DNA priming

University of Michigan, Ann Arbor - New findings in HIV/AIDS prevention described

University of Nebraska, Kearneysville -  D. melanogaster complementary system to study HIV-1-related genes/proteins

University of New South Wales, Darlinghurst - Baseline CD4 count strongest predictor of short-term disease progression in Asia

University of New South Wales, Darlinghurst - CD4:CD8 ratio or CD4 percentage determines risk of progression with HAART

University of New South Wales, Darlinghurst - Intermittent HAART may reduce incidence or slow development of lipoatrophy

University of New South Wales, Sydney - TDF-3TC-d4T most tolerated regimen for nonoccupational postexposure prophylaxis

University of North Carolina, Chapel Hill - Trauma and stress in HIV patients accounted for by increases in PTSD symptoms

University of Texas Medical Branch, Galveston - Hepatitis B vaccine raises antibody in HIV-infected hemodialysis patients

University of Tokushima - Mutant Vif proteins incapable of modulating viral infectivity

University of Toronto - New findings in the area of HIV/AIDS vaccines detailed

University of Virginia, Charlottesville - South African medicinal plant extracts inhibit HIV-1 RT/integrase

Valencia University School of Medicine - Success factors for semen cleansing in men coinfected with HIV and HCV vary

Vita Salute University, Milan - High OPG levels may protect against bone resorption in HIV patients on HAART

YRG CARE, Tamil Nadu - Low-cost assays can monitor HAART patients in developing countries